Axsome Thera
(AXSM)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 26,633 | 34,021 | 31,673 | 37,995 | 45,020 |
| TOTAL | $27,754 | $35,300 | $32,420 | $38,837 | $46,199 |
| Non-Current Assets | |||||
| PPE Net | 71 | 68 | 79 | 87 | 94 |
| Other Non-Current Assets | 115 | 188 | 119 | 119 | 119 |
| TOTAL | $186 | $256 | $199 | $206 | $213 |
| Total Assets | $27,939 | $35,556 | $32,618 | $39,043 | $46,412 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,875 | 3,436 | 2,943 | 4,039 | 4,741 |
| Accrued Expenses | 2,153 | 2,680 | 2,744 | 2,277 | 2,535 |
| Other current liabilities | 118 | 2,791 | N/A | N/A | N/A |
| TOTAL | $9,421 | $12,175 | $8,404 | $8,211 | $8,356 |
| Non-Current Liabilities | |||||
| Long Term Debt | 5,932 | 6,663 | 7,375 | 8,077 | 8,775 |
| TOTAL | $5,932 | $6,663 | $7,375 | $8,077 | $8,775 |
| Total Liabilities | $15,353 | $18,838 | $15,779 | $16,288 | $17,131 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 25,685 | 25,493 | 23,671 | 23,611 | 23,605 |
| Common Shares | 3 | 3 | 2 | 2 | 2 |
| Retained earnings | -81,390 | -76,585 | -69,154 | -62,721 | -55,637 |
| TOTAL | $12,586 | $16,717 | $16,839 | $22,755 | $29,281 |
| Total Liabilities And Equity | $27,939 | $35,556 | $32,618 | $39,043 | $46,412 |